论文部分内容阅读
目的:从中西医结合治疗方面着手,运用甲磺酸倍他司汀片联合强力定眩片治疗后循环缺血性眩晕,从而丰富中西结合治疗后循环缺血性眩晕的治疗方案,提高治疗效果。方法:采用单盲随机对照试验方法,将80例符合纳入标准的后循环缺血性眩晕的患者随机分为2组,对照组给予甲磺酸倍他司汀片治疗;治疗组给予甲磺酸倍他司汀片联合强力定眩片口服治疗,治疗期为7天。治疗前后采用眩晕障碍量表(DHI)进行生活质量评估。结果:采用全分析集(FAS)分析对照组和治疗组有效率,结果分别为92.5%和67.5%,差异有统计学意义(P<0.05)。结论:甲磺酸倍他司汀片联合强力定眩片治疗椎基底动脉供血不足(后循环缺血)引起的眩晕疗效显著,中西结合治疗可以尽快的达到治疗效果,减少治疗周期。
Objective: From the traditional Chinese and Western medicine treatment, the use of betahistine mesylate tablets combined with strong dizziness tablets after treatment of ischemic vertigo, thereby enriching the combination of Chinese and Western treatment of ischemic vertigo treatment after treatment, improve the therapeutic effect. Methods: A single-blind randomized controlled trial was conducted in 80 patients with posterior circulation ischemic vertigo who were enrolled in the standard. Patients in the control group were treated with betahistine mesylate tablets. Methanesulfonic acid Betadine Ting tablets combined with strong dizziness tablets oral treatment, the treatment period of 7 days. Before and after treatment with dizziness disorders scale (DHI) for quality of life assessment. Results: The total analysis set (FAS) analysis of the effective rate of the control group and the treatment group, the results were 92.5% and 67.5%, the difference was statistically significant (P <0.05). Conclusion: The combination of betahistine mesylate tablets and pethidine for the treatment of vertebrobasilar insufficiency (posterior circulation ischemia) caused by dizziness significant effect, the combination of Chinese and Western treatment can achieve the therapeutic effect as soon as possible to reduce the treatment cycle.